Durata Therapeutics, Inc. Deferred Revenue
Durata Therapeutics, Inc. had Deferred Revenue of $11.25 million as of 2014-09-30, per its 10-Q filed 2014-11-07.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2014-11-07
- 2014-09-30: Deferred Revenue $11.25M.
| Period end | Deferred Revenue |
|---|---|
| 2014-09-30 | $11.25M 10-Q · filed 2014-11-07 |